--- title: Oligonucleotide Manufacturing CDMOs in Asia-Pacific path: /services/oligonucleotide-manufacturing/apac companies_count: 9 --- # Oligonucleotide Manufacturing CDMOs in Asia-Pacific 9 published CDMOs match Oligonucleotide Manufacturing in Asia-Pacific. Locations in this set include United States, United Kingdom, China, India, Japan, and Singapore. Capabilities that show up most often in this set: Oligonucleotide, Peptide, Small Molecule, Biologics (Other), and Antibody-Drug Conjugate (ADC). ## Matching companies - [Ajinomoto Bio-Pharma Services](/companies/ajibio-pharma) - Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service. - [Almac Group](/companies/almacgroup) - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities. - [Bachem](/companies/bachem) - Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale. - [Global Biotech Laboratories](/companies/globalbiotechlaboratories) - Global Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents. - [HitGen Inc.](/companies/hitgen) - HitGen Inc. provides drug discovery services built on DNA-encoded library (DEL), fragment-based (FBDD/SBDD) and computational platforms for pharmaceutical and biotech clients. The company also offers oligonucleotide CDMO services and reports serving more than 600 clients globally. - [Pharmaron](/companies/pharmaron) - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK. - [Porton](/companies/portonpharma) - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies. - [Sapala Organics](/companies/sapalaorganics) - Custom synthesis of nucleic acid building blocks, modified phosphoramidites and oligonucleotide delivery compounds, plus FTE-based CRO and fee-for-service CDMO engagements. Orthogonal analytical services serve clients from early R&D through pharma innovators. - [Syngene International](/companies/syngeneintl) - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.